David Millar-Jones examines statements from the European Medicines Agency and MHRA regarding the use of ibuprofen in patients with COVID-19.
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.